Cargando…
Formulary Management of 2 New Agents: Lorcaserin and Phentermine/Topiramate for Weight Loss
BACKGROUND: Obesity may lead to the development of multiple chronic disease states, including hypertension, dyslipidemia, and type 2 diabetes mellitus. Over a half billion adults worldwide are affected by obesity, and more than two-thirds of adults are either obese or overweight in the United States...
Autores principales: | Kelly, Elizabeth M., Tungol, Alexandra A., Wesolowicz, Laurie A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438036/ https://www.ncbi.nlm.nih.gov/pubmed/24074010 http://dx.doi.org/10.18553/jmcp.2013.19.8.642 |
Ejemplares similares
-
Formulary Management of the Protease Inhibitors Boceprevir and Telaprevir for Chronic Hepatitis C Virus
por: Tungol, Alexandra, et al.
Publicado: (2011) -
Formulary Management in the Department of Defense
por: Trice, Shana, et al.
Publicado: (2009) -
Effect of Patient Notification of Formulary Change on Formulary Adherence
por: Delate, Thomas, et al.
Publicado: (2005) -
Clinical Monograph for Drug Formulary Review: Erectile Dysfunction Agents
por: Campbell, Helen Eloise
Publicado: (2005) -
Clinical Monograph for Drug Formulary Review: Systemic Agents for Psoriasis/Psoriatic Arthritis
por: Fisher, Vicki S.
Publicado: (2005)